The global transfection technology market was valued at USD 386.4 million in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value of USD 768.2 million by 2019.
Albany, NY -- (SBWIRE) -- 10/04/2016 -- Transfection is a technique used to introduce nucleic acids (either DNA or RNA) into cells. This technology helps the cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. The report explains various advancements taking place in this market and analyzes the global transfection technology market by types of methods and applications as well as geographic regions. This report comprises an elaborate executive summary, which includes market snapshot that provides overall information of various segments and sub-segments that are contained in the report. Moreover, executive summary comprises waterfall diagram which is drawn on the basis of most desirable segment of the market. Comparative analysis has also been included in the executive summary that resembles percentage market share of each region (North America, Europe, Asia-Pacific, RoW) in 2012 and 2019 respectively.
The global market for transfection technology is segmented based on methods as reagent-based method, instrument-based method and virus-based method. The reagent-based method is further segmented as lipid mediated transfection (Lipofection), calcium phosphate, catonic polymers, DEAE-dextran, activated dendrimers and magnetic beads. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection. The market for these methods has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each method type has been provided for the period 2011 to 2019. The report on the transfection technology market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/1141
In addition, the global market for transfection technology is segmented based on application into biomedical research, therapeutic delivery (biotherapeutics and electro-chemotherapy and electro-immunotherapy) and protein production. Further the biomedical research segment includes transgenic models, cancer research, gene and protein expression studies and cell-based microarrays for drug discovery and development. The market for these applications of transfection technology has been extensively analyzed based on sales revenue of the required technologies and their geographic distribution. The market size and forecast in terms of USD million for each application has been provided for the period 2011 to 2019. The report on the transfection technology market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.
Geographically, the transfection technology market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the transfection technology market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter's five forces analysis and key players' market share analysis in 2012 in the transfection technology market.
Market size estimations involved in-depth study of demand of transfection technology products in hospitals, clinics and research organizations and average price range of each segment. Additionally, disease prevalence, geographic presence and historical year-on-year growth has been taken into consideration for calculating the market size. The market size estimated for each category is based on secondary data obtained for all the above factors cumulatively. The data obtained from secondary research was analyzed extensively and has been validated with the help of industry experts in order to arrive at the most accurate market size estimations. Additionally, we have applied top down approach to estimate the global market figure and assumed percentage split to calculate the market by method and application. The entire transfection technology market has been validated thorough extensive secondary and primary research.
Transfection Technology Market Preview Analysis @ http://www.mrrse.com/transfection-technology/preview-analysis
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report also profiles major players in the transfection technology market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Sigma Aldrich Corporation, SignaGen Laboratories, Lonza Group Ltd., Life Technologies, Bio-Rad Laboratories Inc., Promega Corporation and QIAGEN.
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.